Published in Lancet Oncol on November 26, 2014
Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis. Arthritis Rheumatol (2015) 2.35
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? Nat Rev Clin Oncol (2016) 1.66
The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answers. Chin J Cancer (2017) 1.33
Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer (2015) 1.32
Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocr Relat Cancer (2015) 0.96
The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. J Natl Cancer Inst (2016) 0.94
Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide. J Natl Cancer Inst (2015) 0.90
Measuring the biological effect of presurgical metformin treatment in endometrial cancer. Br J Cancer (2016) 0.88
Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis. Cancer Res (2016) 0.86
Cancer prevention as part of precision medicine: 'plenty to be done'. Carcinogenesis (2015) 0.86
Why does obesity promote cancer? Epidemiology, biology, and open questions. Ecancermedicalscience (2015) 0.83
Influence of BMI on short-term surgical outcome after colorectal cancer surgery: a study based on the Swedish national quality registry. Int J Colorectal Dis (2015) 0.82
Obesity risk in rural, urban and rural-to-urban migrants: prospective results of the PERU MIGRANT study. Int J Obes (Lond) (2015) 0.81
Long-term status and change of body fat distribution, and risk of colorectal cancer: a prospective cohort study. Int J Epidemiol (2015) 0.81
Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Curr Epidemiol Rep (2016) 0.81
Cancer incidence attributable to excess body weight in Alberta in 2012. CMAJ Open (2017) 0.81
Srebp-controlled glucose metabolism is essential for NK cell functional responses. Nat Immunol (2017) 0.79
Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States. Eur J Epidemiol (2016) 0.79
Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex. Cancer Epidemiol Biomarkers Prev (2015) 0.79
The human disease network in terms of dysfunctional regulatory mechanisms. Biol Direct (2015) 0.79
Obesity and cancer, a case for insulin signaling. Cell Death Dis (2015) 0.79
Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer. PLoS One (2016) 0.79
Urban-rural disparity of overweight/obesity distribution and its potential trend with breast cancer among Chinese women. Oncotarget (2016) 0.78
Targeting Inflammation in Cancer Prevention and Therapy. Cancer Prev Res (Phila) (2016) 0.78
The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review. J Diabetes Res (2016) 0.78
Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes Control (2016) 0.78
Childhood body mass index and height and risk of histologic subtypes of endometrial cancer. Int J Obes (Lond) (2016) 0.78
Impact of Chemotherapy on Diet and Nutritional Status of Women with Breast Cancer: A Prospective Study. PLoS One (2016) 0.78
Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. EPMA J (2017) 0.77
Investigating the associations between adiposity, life course overweight trajectories, and telomere length. Aging (Albany NY) (2016) 0.77
Pathways linking obesity to health-related quality of life. Qual Life Res (2017) 0.77
Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States. PLoS Med (2016) 0.76
Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract. Sci Rep (2016) 0.76
Circulating resistin levels and obesity-related cancer risk: A meta-analysis. Oncotarget (2016) 0.76
Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment. Gynecol Oncol (2016) 0.76
Weight Loss Randomized Intervention Trials in Female Cancer Survivors. J Clin Oncol (2016) 0.76
Menu labelling and food choice in obese adults: a feasibility study. BMC Obes (2016) 0.75
Bariatric Surgery Prior to Index Screening Colonoscopy Is Associated With a Decreased Rate of Colorectal Adenomas in Obese Individuals. Clin Transl Gastroenterol (2017) 0.75
Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis. PLoS One (2015) 0.75
Feasibility of body roundness index for identifying a clustering of cardiometabolic abnormalities compared to BMI, waist circumference and other anthropometric indices: the China Health and Nutrition Survey, 2008 to 2009. Medicine (Baltimore) (2016) 0.75
Evaluation of in vitro cytotoxicity, biocompatibility, and changes in the expression of apoptosis regulatory proteins induced by cerium oxide nanocrystals. Sci Technol Adv Mater (2017) 0.75
Maximizing Weight Loss After Roux-en-Y Gastric Bypass May Decrease Risk of Incident Organ Cancer. Obes Surg (2016) 0.75
Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecol Oncol (2017) 0.75
Excess weight as a risk factor common to many cancer sites: words of caution when interpreting meta-analytic evidence. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Excess weight causes nearly 4% of new cancers a year worldwide. BMJ (2014) 0.75
AACR Cancer Progress Report 2015. Clin Cancer Res (2015) 0.75
Comment on "Acute lymphoblastic leukemia and adiponcosis" by M. Bifilco and AM Malfitano. Haematologica (2015) 0.75
Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer. BMC Cancer (2016) 0.75
Weight Loss and Mortality in Overweight and Obese Cancer Survivors: A Systematic Review. PLoS One (2017) 0.75
Obesity is associated with increased risk of invasive penile cancer. BMC Urol (2016) 0.75
Cancer and high body-mass index: global burden, global effort? Lancet Oncol (2014) 0.75
Strengthening the evidence base for nutrition and cancer in low and middle income countries. J Glob Health (2016) 0.75
Towards an Obesity-Cancer Knowledge Base: Biomedical Entity Identification and Relation Detection. Proceedings (IEEE Int Conf Bioinformatics Biomed) (2017) 0.75
Investigating nutrition and lifestyle factors as determinants of abdominal obesity: an environment-wide study. Int J Obes (Lond) (2016) 0.75
Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational study. Int J Cancer (2017) 0.75
Body-mass index, cancer, and implications for screening. Lancet Oncol (2015) 0.75
Obesity and kidney disease: Hidden consequences of the epidemic. Indian J Nephrol (2017) 0.75
Salt-inducible kinases mediate nutrient-sensing to link dietary sugar and tumorigenesis in Drosophila. Elife (2015) 0.75
Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study. J Obes (2015) 0.75
Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Kidney Dis (Basel) (2017) 0.75
Obesity and Breast Cancer: Do Age, Race and Subtype Matter? BAOJ Cancer Res Ther (2016) 0.75
Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies. Diabetologia (2016) 0.75
Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol (2017) 0.75
Zero-Inflated Models for Identifying Relationships Between Body Mass Index and Gastroesophageal Reflux Symptoms: A Nationwide Population-Based Study in China. Dig Dis Sci (2016) 0.75
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med (2017) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Pediatr Nephrol (2017) 0.75
Obesity, adiposopathy, and quantitative imaging biomarkers. Radiol Bras (2017) 0.75
Investigation Of Obesity-Related Mortality Rates In Delaware. Am J Health Sci (2017) 0.75
An Ecological Study of the Association between Opiate Use and Incidence of Cancers. Addict Health (2016) 0.75
Colorectal Cancer Screening in Asia. Curr Gastroenterol Rep (2017) 0.75
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy. Immunotherapy (2017) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Clin Kidney J (2017) 0.75
Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage? Int J Clin Oncol (2017) 0.75
Establishing failure predictors for the planned extubation of overweight and obese patients. PLoS One (2017) 0.75
Dose-response effects of aerobic exercise on energy compensation in postmenopausal women: combined results from two randomized controlled trials. Int J Obes (Lond) (2017) 0.75
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet (2003) 18.24
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev (2007) 16.67
Use and misuse of population attributable fractions. Am J Public Health (1998) 12.96
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr (2004) 8.87
Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet (2014) 6.61
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA (2014) 6.42
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr (2012) 4.13
Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr (2005) 3.93
The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol (2011) 3.22
The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study. PLoS Med (2010) 3.16
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr (2009) 2.80
Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer (2005) 2.62
Slowing down of adult body mass index trend increases in England: a latent class analysis of cross-sectional surveys (1992-2010). Int J Obes (Lond) (2013) 2.34
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut (2007) 2.28
Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med (2012) 2.22
Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer (2010) 1.93
Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev (2011) 1.86
BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord (2004) 1.85
Global incidence of oesophageal cancer by histological subtype in 2012. Gut (2014) 1.84
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur J Cancer (2013) 1.51
Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA (2013) 1.51
Urban-rural differences in BMI in low- and middle-income countries: the role of socioeconomic status. Am J Clin Nutr (2013) 1.39
Categorical versus continuous risk factors and the calculation of potential impact fractions. J Epidemiol Community Health (2009) 1.37
The obesity epidemic slows among the middle-aged population in Sweden while the socioeconomic gap widens. Glob Health Action (2010) 1.29
Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe. Eur J Cancer (2010) 1.24
Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev (2013) 1.23
Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2009) 1.22
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control (2010) 1.21
Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study. Int J Obes Relat Metab Disord (2003) 1.20
Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer (2011) 1.16
8. Cancers attributable to overweight and obesity in the UK in 2010. Br J Cancer (2011) 1.15
Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev (2014) 1.15
Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet (2012) 1.03
Obesity and overweight trends in Catalonia, Spain (1992-2003): gender and socio-economic determinants. Public Health Nutr (2007) 1.03
Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. Am J Clin Nutr (2013) 1.01
Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women's Health Initiative Observational Study. Am J Epidemiol (2011) 1.01
Excess weight in the canton of Zurich, 1992-2009: harbinger of a trend reversal in Switzerland? Swiss Med Wkly (2010) 0.95
Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010. Eur J Cancer (2013) 0.95
Weight change in adult life and health outcomes. Obes Res (2005) 0.92
Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? J Clin Oncol (2007) 0.83
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr (2012) 4.13
Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study. Lancet (2014) 3.76
Trends and mortality effects of vitamin A deficiency in children in 138 low-income and middle-income countries between 1991 and 2013: a pooled analysis of population-based surveys. Lancet Glob Health (2015) 2.97
Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology (2013) 2.19
Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet (2015) 2.15
Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study. Lancet Glob Health (2015) 1.93
Global incidence of oesophageal cancer by histological subtype in 2012. Gut (2014) 1.84
Children's height and weight in rural and urban populations in low-income and middle-income countries: a systematic analysis of population-representative data. Lancet Glob Health (2013) 1.63
Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects. Am J Gastroenterol (2016) 1.54
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur J Cancer (2013) 1.51
Global patterns and trends in colorectal cancer incidence and mortality. Gut (2016) 1.45
International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol Biomarkers Prev (2015) 1.25
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol (2016) 1.14
Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int J Cancer (2015) 1.04
Nutrient patterns and their food sources in an International Study Setting: report from the EPIC study. PLoS One (2014) 0.84
Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Curr Epidemiol Rep (2016) 0.81
Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex. Cancer Epidemiol Biomarkers Prev (2015) 0.79
Breast cancer diagnosis, patterns of care and burden of disease in Queensland, Australia (1998-2004): does being Indigenous make a difference? Int J Public Health (2015) 0.78
Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States. PLoS Med (2016) 0.76
International trends in anal cancer incidence rates. Int J Epidemiol (2016) 0.76
Response to Crocetti et al. Am J Gastroenterol (2016) 0.75
Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut (2020) 0.75
Cohort profile: a nationwide cohort of Finnish military recruits born in 1958 to study the impact of lifestyle factors in early adulthood on disease outcomes. BMJ Open (2017) 0.75
New cancer cases in France in 2015 attributable to different levels of alcohol consumption. Addiction (2017) 0.75
Profile of cancer in the Eastern Mediterranean region: The need for action. Cancer Epidemiol (2017) 0.75
Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol (2017) 0.75
Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology (2017) 0.75
Obesity as an Avoidable Cause of Cancer (Attributable Risks). Recent Results Cancer Res (2016) 0.75
Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. Int J Cancer (2017) 0.75
Cancer of childhood in sub-Saharan Africa. Ecancermedicalscience (2017) 0.75
Cancers of the brain and CNS: global patterns and trends in incidence. Neuro Oncol (2017) 0.75
Performance indicators in breast cancer screening in the European Union: A comparison across countries of screen positivity and detection rates. Int J Cancer (2020) 0.75
Cervical cancer burden in Latin America and the Caribbean: Where are we? Int J Cancer (2020) 0.75
RE: Anal cancer-different epidemiological and clinical definitions. Int J Epidemiol (2017) 0.75